CSPG4P5

Across TCGA pan-cancer cohorts, CSPG4P5 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CSPG4P5’s most consistent transcriptional readouts.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where CSPG4P5 RNA is repressed in tumor relative to normal tissue. In most cancer types CSPG4P5 is over-expressed in tumor, although a few such as PAAD and PRAD show the opposite, repressed pattern.

PAAD, PRAD, and BRCA are the cancer types where CSPG4P5 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CSPG4P5 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
PAAD	Female	All	−0.025	.037	2	view →
PRAD	All	All	−0.005	.019	2	view →
BRCA	All	All	+0.004	.033	2	view →
KICH	All	II,III,IV	+0.005	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

CSPG4P5–PAAD

Open the PAAD breakdown →